Close Menu

PMC

The industry standards issued last December by 23andMe, Decode, and Navigenics are "a good start, but they are really not where they need to be," said Muin Khoury, director of the CDC's Office of Public Health Genomics.

The issue is divisive in that results from a comparative effectiveness study could alter how insurers reimburse certain drugs and diagnostics, which could in turn change physicians' prescribing habits.

Pairings: Apr 15, 2009

Premium

Patrick Terry, Lisa Wise, James O'Leary

Jack Lord is named president and CEO of Navigenics, while Celera has a new CFO, and Patrick Terry joins the board of directors of TcLand Expression, plus more.

The Senate will consider an amendment that would add a personalized medicine clause to the 2010 budget, but also would change the comparative effectiveness approach.

Industry stakeholders and patient advocates are urging the government to ensure that any resulting comparative effectiveness program not focus solely on reducing cost but on using pharmacogenomics to improve patient outcomes.

Snippets: Feb 25, 2009

Premium

Myriad Genetics, Kinaxo Biotechnologies, Bavarian Research Foundation, European Commission, Decode Genetics, Ontario Institute for Cancer Research

In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.

Pages

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.